Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 60.30%265.3M | 2.31%199.5M | -27.24%79.6M | 40.48%661.1M | 57.54%192.2M | 47.11%165.5M | 37.52%195M | 16.01%109.4M | 57.65%470.6M | 19.26%122M |
| Net income from continuing operations | 226.98%276.3M | 127.39%159.4M | -63.90%15.2M | 35.38%284.3M | 85.99%87.6M | 114.47%84.5M | -6.66%70.1M | -13.02%42.1M | 466.04%210M | 16.01%47.1M |
| Operating gains losses | 211.07%81.5M | 32,300.00%32.4M | 2,733.33%68M | 266.67%17M | -56.00%-11.7M | 2,481.82%26.2M | 108.33%100K | 2,300.00%2.4M | -59.38%-10.2M | -66.67%-7.5M |
| Depreciation and amortization | -9.88%52M | 0.57%52.7M | 2.80%51.4M | 14.83%218.4M | 15.22%58.3M | 22.25%57.7M | 13.67%52.4M | 7.99%50M | 10.90%190.2M | 10.96%50.6M |
| Asset impairment expenditure | -283.19%-218.8M | ---- | ---- | ---52.4M | --4.7M | ---57.1M | ---- | ---- | --0 | --0 |
| Remuneration paid in stock | 64.23%22.5M | -48.39%3.2M | 226.26%32.3M | 46.08%31.7M | -69.84%1.9M | 661.11%13.7M | 148.00%6.2M | -10.81%9.9M | 18.58%21.7M | -11.27%6.3M |
| Deferred tax | 67.90%95.2M | -61.79%22.2M | -68.66%10.5M | 160.33%217.9M | 1,597.56%69.6M | 46.13%56.7M | 241.76%58.1M | 40.76%33.5M | 28.18%83.7M | -65.83%4.1M |
| Other non cashItems | -400.90%-33.4M | -980.95%-37M | -1,740.00%-46M | -121.02%-3.3M | -227.97%-15.1M | 56.34%11.1M | 450.00%4.2M | 0.00%-2.5M | -56.02%15.7M | 78.79%11.8M |
| Change In working capital | 63.37%-10M | -956.41%-33.4M | -99.23%-51.8M | 145.12%17.1M | 445.08%66.5M | -31.88%-27.3M | 11.43%3.9M | 20.97%-26M | 38.67%-37.9M | 314.04%12.2M |
| -Change in receivables | ---- | ---- | ---- | 119.85%2.7M | ---- | ---- | ---- | ---- | -54.55%-13.6M | ---- |
| -Change in inventory | ---- | ---- | ---- | 305.00%53.3M | ---- | ---- | ---- | ---- | 52.90%-26M | ---- |
| -Change in prepaid assets | ---- | ---- | ---- | 433.33%2M | ---- | ---- | ---- | ---- | -126.09%-600K | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | -1,878.26%-40.9M | ---- | ---- | ---- | ---- | 2,400.00%2.3M | ---- |
| Interest received (cash flow from operating activities) | ---- | ---- | ---- | 61.54%12.6M | ---- | ---- | ---- | ---- | 310.53%7.8M | ---- |
| Tax refund paid | ---- | ---- | ---- | -890.36%-82.2M | ---- | ---- | ---- | ---- | -538.46%-8.3M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 60.30%265.3M | 2.31%199.5M | -27.24%79.6M | 39.86%661.1M | 54.88%192.2M | 47.11%165.5M | 37.52%195M | 16.01%109.4M | 58.36%472.7M | 21.31%124.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -20.63%-133.9M | 2.78%-122.2M | -20.36%-101.7M | -32.77%-467.1M | -32.88%-145.9M | -45.48%-111M | -55.38%-125.7M | 0.35%-84.5M | -12.50%-351.8M | -29.33%-109.8M |
| Capital expenditure reported | ---4.3M | ---6.9M | ---2M | ---7.7M | ---7.7M | --0 | --0 | --0 | --0 | ---- |
| Net PPE purchase and sale | -26.40%-135M | -31.16%-114.9M | -17.99%-99.7M | -19.69%-417.6M | -26.44%-138.7M | -42.02%-106.8M | -9.23%-87.6M | -0.84%-84.5M | -11.22%-348.9M | -29.36%-109.7M |
| Net business purchase and sale | --0 | --0 | ---- | ---30.2M | --0 | --6.7M | ---36.9M | ---- | --0 | --0 |
| Net investment purchase and sale | 151.38%5.6M | 900.00%1.6M | ---- | -292.59%-10.6M | 600.00%500K | -890.91%-10.9M | 60.00%-200K | --0 | 32.50%-2.7M | 0.00%-100K |
| Interest received (cash flow from investment activities) | ---4.3M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | ---200K | -100.00%-2M | ---- | -400.00%-1M | --0 | ---- | -400.00%-1M | ---- | ---200K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -20.63%-133.9M | 2.78%-122.2M | -20.36%-101.7M | -32.77%-467.1M | -32.88%-145.9M | -45.48%-111M | -55.38%-125.7M | 0.35%-84.5M | -12.50%-351.8M | -29.33%-109.8M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 82.32%-13.4M | -512.96%-22.3M | -60.42%-15.4M | -243.85%-89.4M | -85.71%-10.4M | -835.80%-75.8M | 180.60%5.4M | -71.43%-9.6M | 8.45%-26M | -12.00%-5.6M |
| Net issuance payments of debt | 93.25%-4.3M | ---4M | ---4.3M | ---68.9M | ---5.2M | ---63.7M | --0 | --0 | --0 | --0 |
| Net common stock issuance | --0 | -195.24%-10M | ---- | --10.5M | --0 | --0 | --10.5M | ---- | --0 | --0 |
| Cash dividends paid | -13.48%-10.1M | -14.29%-9.6M | -11.49%-9.7M | 0.57%-35.1M | -5.81%-9.1M | -2.30%-8.9M | 4.55%-8.4M | 5.43%-8.7M | -0.57%-35.3M | 2.27%-8.6M |
| Proceeds from stock option exercised by employees | -13.33%1.3M | -57.89%1.6M | -60.00%200K | -26.88%6.8M | -66.67%1M | 150.00%1.5M | 80.95%3.8M | -86.11%500K | 75.47%9.3M | -34.78%3M |
| Interest paid (cash flow from financing activities) | ---- | ---- | -14.29%-1.6M | ---2.7M | --2.9M | ---4.7M | --0 | ---1.4M | --0 | --0 |
| Net other financing activities | 93.62%-300K | 40.00%-300K | ---- | ---2.7M | ---- | ---4.7M | ---500K | ---900K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 82.32%-13.4M | -512.96%-22.3M | -60.42%-15.4M | -243.85%-89.4M | -85.71%-10.4M | -835.80%-75.8M | 180.60%5.4M | -71.43%-9.6M | 8.45%-26M | -12.00%-5.6M |
| Net cash flow | ||||||||||
| Beginning cash position | 9.98%344.9M | 20.52%289.5M | 45.55%327.2M | 73.19%224.8M | 35.06%291.6M | 66.28%313.6M | 79.52%240.2M | 73.19%224.8M | -24.75%129.8M | 85.00%215.9M |
| Current changes in cash | 653.99%118M | -26.37%55M | -345.10%-37.5M | 10.22%104.6M | 312.64%35.9M | -175.80%-21.3M | 37.82%74.7M | 292.31%15.3M | 322.77%94.9M | -29.84%8.7M |
| Effect of exchange rate changes | 128.57%200K | 130.77%400K | -300.00%-200K | -2,300.00%-2.2M | -250.00%-300K | 12.50%-700K | -316.67%-1.3M | 0.00%100K | 200.00%100K | -71.43%200K |
| End cash Position | 58.81%463.1M | 9.98%344.9M | 20.52%289.5M | 45.55%327.2M | 45.55%327.2M | 35.06%291.6M | 66.28%313.6M | 79.52%240.2M | 73.19%224.8M | 73.19%224.8M |
| Free cash from | 114.65%126M | -27.65%77.7M | -188.76%-22.1M | 90.47%235.8M | 218.06%45.8M | 57.37%58.7M | 74.35%107.4M | 137.14%24.9M | 914.47%123.8M | -17.71%14.4M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.